Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | |
| Sales | 31,798 | 19,508 | 5,398 |
| Cost of Goods | 13,820 | 11,708 | 8,948 |
| Gross Profit | 17,978 | 7,800 | -3,550 |
| Operating Expenses | 68,799 | 52,403 | 31,824 |
| Operating Income | -50,001 | -43,895 | -34,426 |
| Interest Expense | 7,652 | 6,386 | 4,306 |
| Other Income | 592 | 172 | -4,405 |
| Pre-tax Income | -57,061 | -50,109 | -43,137 |
| Income Tax | 312 | 199 | 175 |
| Net Income Continuous | -57,373 | -50,308 | -43,312 |
| Net Income | $-57,373 | $-50,308 | $-43,312 |
| EPS Basic Total Ops | -3.95 | -87.42 | -101.97 |
| EPS Basic Continuous Ops | -3.95 | -87.49 | -101.91 |
| EPS Diluted Total Ops | -3.95 | -87.42 | -101.97 |
| EPS Diluted Continuous Ops | -3.95 | -87.49 | -101.91 |
| EPS Diluted Before Non-Recurring Items | -3.95 | -5.01 | -5.89 |
| EBITDA(a) | $-48,766 | $-42,416 | $-31,630 |